These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

352 related items for PubMed ID: 28641289

  • 1. Impact of Comorbid Irritable Bowel Syndrome on Treatment Outcome in Non-Erosive Reflux Disease on Long-Term Proton Pump Inhibitor in Japan.
    Funaki Y, Kaneko H, Kawamura Y, Yoshimine T, Tamura Y, Izawa S, Ebi M, Ogasawara N, Sasaki M, Kasugai K.
    Digestion; 2017; 96(1):39-45. PubMed ID: 28641289
    [Abstract] [Full Text] [Related]

  • 2. The influence of co-morbid IBS and psychological distress on outcomes and quality of life following PPI therapy in patients with gastro-oesophageal reflux disease.
    Nojkov B, Rubenstein JH, Adlis SA, Shaw MJ, Saad R, Rai J, Weinman B, Chey WD.
    Aliment Pharmacol Ther; 2008 Mar 15; 27(6):473-82. PubMed ID: 18194508
    [Abstract] [Full Text] [Related]

  • 3. Risk factors for proton pump inhibitor refractoriness in Chinese patients with non-erosive reflux disease.
    Niu XP, Yu BP, Wang YD, Han Z, Liu SF, He CY, Zhang GZ, Wu WC.
    World J Gastroenterol; 2013 May 28; 19(20):3124-9. PubMed ID: 23716993
    [Abstract] [Full Text] [Related]

  • 4. Impact of coexisting irritable bowel syndrome and non-erosive reflux disease on postprandial abdominal fullness and sleep disorders in functional dyspepsia.
    Futagami S, Yamawaki H, Shimpuku M, Izumi N, Wakabayashi T, Kodaka Y, Nagoya H, Shindo T, Kawagoe T, Sakamoto C.
    J Nippon Med Sch; 2013 May 28; 80(5):362-70. PubMed ID: 24189354
    [Abstract] [Full Text] [Related]

  • 5. [Symptom overlaps between functional heartburn, functional dyspepsia, and irritable bowel syndrome].
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2014 May 28; 45(3):489-92. PubMed ID: 24941825
    [Abstract] [Full Text] [Related]

  • 6. Impact of Overlapping Functional Gastrointestinal Disorders on the Presentation and Quality of Life of Patients with Erosive Esophagitis and Nonerosive Reflux Disease.
    Lee SW, Chang CS, Lien HC, Peng YC, Wu CY, Yeh HZ.
    Med Princ Pract; 2015 May 28; 24(5):491-5. PubMed ID: 26137901
    [Abstract] [Full Text] [Related]

  • 7. Prevalence and clinical characteristics of refractoriness to optimal proton pump inhibitor therapy in non-erosive reflux disease.
    Ribolsi M, Cicala M, Zentilin P, Neri M, Mauro A, Efthymakis K, Petitti T, Savarino V, Penagini R.
    Aliment Pharmacol Ther; 2018 Nov 28; 48(10):1074-1081. PubMed ID: 30294924
    [Abstract] [Full Text] [Related]

  • 8. Concomitant irritable bowel syndrome is associated with failure of step-down on-demand proton pump inhibitor treatment in patients with gastro-esophageal reflux disease.
    Wu JC, Lai LH, Chow DK, Wong GL, Sung JJ, Chan FK.
    Neurogastroenterol Motil; 2011 Feb 28; 23(2):155-60, e31. PubMed ID: 21087355
    [Abstract] [Full Text] [Related]

  • 9. Irsogladine maleate and rabeprazole in non-erosive reflux disease: A double-blind, placebo-controlled study.
    Suzuki T, Matsushima M, Masui A, Tsuda S, Imai J, Nakamura J, Tsukune Y, Uchida T, Yuhara H, Igarashi M, Koike J, Mine T.
    World J Gastroenterol; 2015 Apr 28; 21(16):5023-31. PubMed ID: 25945018
    [Abstract] [Full Text] [Related]

  • 10. Influence of irritable bowel syndrome on treatment outcome in gastroesophageal reflux disease.
    Mönnikes H, Heading RC, Schmitt H, Doerfler H.
    World J Gastroenterol; 2011 Jul 21; 17(27):3235-41. PubMed ID: 21912473
    [Abstract] [Full Text] [Related]

  • 11. Dyspepsia and IBS symptoms in patients with NERD, ERD and Barrett's esophagus.
    Neumann H, Monkemuller K, Kandulski A, Malfertheiner P.
    Dig Dis; 2008 Jul 21; 26(3):243-7. PubMed ID: 18463443
    [Abstract] [Full Text] [Related]

  • 12. Randomised clinical trial: sustained response to PPI treatment of symptoms resembling functional dyspepsia and irritable bowel syndrome in patients suffering from an overlap with erosive gastro-oesophageal reflux disease.
    Mönnikes H, Schwan T, van Rensburg C, Straszak A, Theek C, Sander P, Lühmann R.
    Aliment Pharmacol Ther; 2012 Jun 21; 35(11):1279-89. PubMed ID: 22486552
    [Abstract] [Full Text] [Related]

  • 13. Anxiety and depression in patients with gastroesophageal reflux disease and their effect on quality of life.
    Yang XJ, Jiang HM, Hou XH, Song J.
    World J Gastroenterol; 2015 Apr 14; 21(14):4302-9. PubMed ID: 25892882
    [Abstract] [Full Text] [Related]

  • 14. Efficacy of the addition of prokinetics for proton pump inhibitor (PPI) resistant non-erosive reflux disease (NERD) patients: significance of frequency scale for the symptom of GERD (FSSG) on decision of treatment strategy.
    Miyamoto M, Manabe N, Haruma K.
    Intern Med; 2010 Apr 14; 49(15):1469-76. PubMed ID: 20686276
    [Abstract] [Full Text] [Related]

  • 15. Reflux and irritable bowel syndrome are negative predictors of quality of life in coeliac disease and inflammatory bowel disease.
    Barratt SM, Leeds JS, Robinson K, Shah PJ, Lobo AJ, McAlindon ME, Sanders DS.
    Eur J Gastroenterol Hepatol; 2011 Feb 14; 23(2):159-65. PubMed ID: 21178777
    [Abstract] [Full Text] [Related]

  • 16. Nondigestive symptoms in non-erosive reflux disease: nature, prevalence and relation to acid reflux.
    Hershcovici T, Zimmerman J.
    Aliment Pharmacol Ther; 2008 Nov 01; 28(9):1127-33. PubMed ID: 18702676
    [Abstract] [Full Text] [Related]

  • 17. More severe upper gastrointestinal symptoms associated with non-erosive reflux disease than with erosive gastroesophageal reflux disease during maintenance proton pump inhibitor therapy.
    Kusano M, Hosaka H, Kawamura O, Kawada A, Kuribayashi S, Shimoyama Y, Yasuoka H, Mizuide M, Tomizawa T, Sagawa T, Sato K, Yamada M.
    J Gastroenterol; 2015 Mar 01; 50(3):298-304. PubMed ID: 24919745
    [Abstract] [Full Text] [Related]

  • 18. Bowel symptoms in nonerosive gastroesophageal reflux disease: nature, prevalence, and relation to acid reflux.
    Zimmerman J, Hershcovici T.
    J Clin Gastroenterol; 2008 Mar 01; 42(3):261-5. PubMed ID: 18223499
    [Abstract] [Full Text] [Related]

  • 19. Clinical, metabolic, and psychological characteristics in patients with gastroesophageal reflux disease overlap with irritable bowel syndrome.
    Hsu CS, Liu TT, Wen SH, Wang CC, Yi CH, Chen JH, Lei WY, Orr WC, Fabio P, Chen CL.
    Eur J Gastroenterol Hepatol; 2015 May 01; 27(5):516-22. PubMed ID: 25822860
    [Abstract] [Full Text] [Related]

  • 20. Clinical symptoms of FSSG in gastroesophageal reflux disease are critical for PPI treatment: Japanese multi-centers with 185 patients.
    Komatsu-Tanaka M, Iwakiri R, Fujimoto K, Fujiwara Y, Inamori M, Tanaka J, Shimatani T, Akiyama J, Ando T, Manabe N, Kinjo F, Deguchi R, Kusano M.
    Dig Endosc; 2012 Nov 01; 24(6):407-11. PubMed ID: 23078431
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.